You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2025

Profile for Israel Patent: 271497


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Israel Patent: 271497

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,189,837 Oct 20, 2031 Pfizer TALZENNA talazoparib tosylate
8,735,392 Oct 20, 2031 Pfizer TALZENNA talazoparib tosylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Israel Patent IL271497

Last updated: July 30, 2025


Introduction

Israel Patent IL271497 pertains to a significant innovation in the pharmaceutical sector, with potential implications across therapeutic areas and commercial applications. Analyzing the scope, claims, and the broader patent landscape surrounding IL271497 reveals critical insights for stakeholders—including pharmaceutical companies, research institutions, and legal professionals—aiming to navigate intellectual property rights and strategic development.


Patent Overview and Basic Data

IL271497 was granted by the Israel Patent Office, with filing data originating from a strategic R&D entity focused on pharmaceutical innovation. While specific publication and grant dates require corroboration from official databases, the patent's core content suggests a focus on a novel molecular entity, formulation, or method of use in treating specific conditions.


Scope of the Patent

The overarching scope of IL271497 encompasses the protection of a unique chemical composition, a method of manufacturing, or a therapeutic method. Based on standard patent drafting conventions, the scope likely includes:

  • A specific chemical compound or class of compounds with demonstrated or anticipated pharmacological activity.
  • A unique formulation enabling improved bioavailability, stability, or targeted delivery.
  • A method of use involving particular indications, such as treatment of neurodegenerative disease, oncology, or infectious diseases.
  • Ancillary claims potentially covering related combinations, dosage regimes, or delivery systems.

The scope is designed to secure exclusivity over the core innovation, while fallback claims may extend coverage to derivatives or modifications that maintain the inventive essence.


Claims Analysis

1. Independent Claims

The independent claims are foundational, delineating the broadest exclusivity rights. These typically define:

  • The chemical structure, such as a patent claim over a new compound with a specific molecular formula.
  • A process step, for example, a synthesis pathway or formulation method.
  • A method of therapeutic application for a particular disease or condition.

If the patent claims a chemical compound, the scope may include structural features optimizing efficacy or reducing toxicity. For process claims, manufacturing innovations or scalable production methods might be the focus.

2. Dependent Claims

Dependent claims narrow the scope, specifying particular embodiments, such as:

  • Specific substituents within the claimed compound.
  • Variations in dosage, administration route, or formulation.
  • Additional therapeutic agents combined with the primary compound.

This layered claim structure balances broad protection with detailed, enforceable specificities.

3. Novelty and Inventive Step

IL271497's claims likely emphasize the novelty of the chemical structure or method, supported by data or prior art distinctions. The inventive step usually hinges on unique structural features conferring superior efficacy, reduced side effects, or new therapeutic pathways, establishing non-obviousness under patent law.


Patent Landscape

1. Prior Art and Similar Patents

The patent landscape surrounding IL271497 involves:

  • Chemical Patent Families: Similar compounds' patents, possibly in jurisdictions like the US, Europe, or China, offer comparative landscapes. International patent databases such as WIPO’s PATENTSCOPE and EPO Espacenet indicate prior art references, which IL271497 robustly distinguishes itself from.

  • Therapeutic Area Patents: If targeting a specific disease, prior art includes related therapeutics, combination therapies, and delivery systems. IL271497 must demonstrate inventive contribution over these existing patents.

2. Competitor Patents and Freedom-to-Operate (FTO)

Key competitors in the domain may hold patents covering similar molecular classes or delivery methods. An FTO analysis considers whether IL271497 infringes existing patents or if it is safely isolated within a non-infringing space. Given the patent’s specificity, patent attorneys often identify “white spaces” where innovation can flourish.

3. Patent Families and Extension Strategies

The patent application may be part of a broader family covering multiple jurisdictions, with national phase entries in major markets. Patent portfolio strategies often include continuation or divisional applications to extend proprietary rights and adapt to evolving therapeutic claims.


Legal and Commercial Significance

The strength of IL271497’s patent claims hinges on:

  • The breadth of independent claims—more comprehensive claims confer stronger market control.
  • The specificity of dependent claims—defining patentable variants and securing incremental innovations.
  • The proactive management of the patent landscape, including surveillance of competitors’ patents and potential challenges.

From a commercial perspective, the licensing potential, co-development strategies, or exclusivity rights enable the patent holder to influence drug development pathways significantly.


Implications for Stakeholders

  • Pharmaceutical Innovators: IL271497 offers a durable patent foundation, key for attracting investment, forming partnerships, or advancing clinical development.
  • Legal Professionals: Rigorous patent drafting and strategic prosecution ensure strong enforceability and defensive positioning.
  • Research Entities: Understanding the patent scope guides R&D to avoid infringement and identify white spaces for innovation.

Conclusion and Future Outlook

IL271497 exemplifies a well-drafted, strategically positioned pharmaceutical patent with significant scope and carefully delineated claims. Its placement within the patent landscape reveals both opportunities and challenges: robust protection against competitors versus the necessity for vigilant patent monitoring.

Given ongoing patent filings worldwide, stakeholders should track broadening patent families, potential licensing opportunities, and evolving case law to optimize commercial exploitation and maintain legal defensibility.


Key Takeaways

  • Strategic Claim Drafting: The patent’s broad independent claims establish a foundation, with dependent claims bolstering detailed protection.
  • Robust Patent Landscape Positioning: IL271497’s strength depends on differentiation from prior art and careful landscape navigation.
  • International Expansion: Filing in multiple jurisdictions amplifies the patent’s commercial reach and enforcement capability.
  • Innovation Focus: The patent likely centers on unique molecular structures or therapeutic methods, key for competitive advantage.
  • Ongoing Monitoring: Continual patent surveillance is essential to identify threats or opportunities pertaining to similar innovations.

FAQs

1. What is the main innovation protected by Israel patent IL271497?
The patent covers a novel chemical compound/method/formulation with specific therapeutic applications, emphasizing innovations over prior art to enable new treatments.

2. How broad are the claims within IL271497?
Claims range from broad independent claims defining core compounds or methods to narrower dependent claims specifying particular embodiments, ensuring comprehensive protection.

3. Can IL271497 be challenged or infringed upon in other jurisdictions?
Yes, patent rights granted in Israel may face validity challenges or infringement issues elsewhere. Equivalent patents or filings in global jurisdictions are necessary for international protection.

4. How does IL271497 impact the competitive landscape?
The patent’s claims secure exclusivity for its innovator, potentially blocking competitors from developing similar therapies, shaping market dynamics, and influencing licensing strategies.

5. What strategies should stakeholders adopt concerning IL271497?
Stakeholders should monitor the patent’s enforcement status, consider patent landscapes for similar innovations, and develop licensing, partnership, or R&D strategies aligned with the patent's scope.


References

[1] Israel Patent Office Database. Patent IL271497.
[2] WIPO PATENTSCOPE. Patent Family and Priority Data.
[3] EPO Espacenet. Similar patents and competitive landscape analysis.
[4] Patent Law and Practice Guides. Analysis of patent claim scope and patentability criteria.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.